1. Carrageenan-stabilized Chitosan Alginate Nanoparticles Loaded with Ethionamide for the Treatment of Tuberculosis. Abdelghany, S., M. Alkhawaldeh, and H.S. AlKhatib. Journal of Drug Delivery Science and Technology, 2017. 39: p. 442-449. ISI[000404312200049].
[WOS]. TB_07_2017.
2. Discovery of a New Mycobacterium tuberculosis Thymidylate Synthase X Inhibitor with a Unique Inhibition Profile. Abu El Asrar, R., L. Margamuljana, H. Klaassen, M. Nijs, A. Marchand, P. Chaltin, H. Myllykallio, H.F. Becker, S. De Jonghe, P. Herdewijn, and E. Lescrinier. Biochemical Pharmacology, 2017. 135: p. 69-78. PMID[28359706].
[PubMed]. TB_07_2017.
3. Development of a Novel Lead That Targets M. tuberculosis Polyketide Synthase 13. Aggarwal, A., M.K. Parai, N. Shetty, D. Wallis, L. Woolhiser, C. Hastings, N.K. Dutta, S. Galaviz, R.C. Dhakal, R. Shrestha, S. Wakabayashi, C. Walpole, D. Matthews, D. Floyd, P. Scullion, J. Riley, O. Epemolu, S. Norval, T. Snavely, G.T. Robertson, E.J. Rubin, T.R. Ioerger, F.A. Sirgel, R. van der Merwe, P.D. van Helden, P. Keller, E.C. Bottger, P.C. Karakousis, A.J. Lenaerts, and J.C. Sacchettini. Cell, 2017. 170(2): p. 249-259 e225. PMID[28669536]. PMCID[PMC5509550].
[PubMed]. TB_07_2017.
4. Antioxidant, Antigenotoxic, Antimicrobial Activities and Phytochemical Analysis of Dianthus carmelitarum. Aliyazicioglu, R., S. Demir, M. Badem, S.O. Sener, N. Korkmaz, E.A. Demir, U. Ozgen, S.A. Karaoglu, and Y. Aliyazicioglu. Records of Natural Products, 2017. 11(3): p. 270-284. ISI[000403499200004].
[WOS]. TB_07_2017.
5. Beta-CA-specific Inhibitor Dithiocarbamate Fc14-584B: A Novel Antimycobacterial Agent with Potential to Treat Drug-resistant Tuberculosis. Aspatwar, A., M. Hammaren, S. Koskinen, B. Luukinen, H. Barker, F. Carta, C.T. Supuran, M. Parikka, and S. Parkkila. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017. 32(1): p. 832-840. PMID[28629306].
[PubMed]. TB_07_2017.
6. Synthesis and Biological Evaluation of Novel 1,2,3-Triazole Derivatives as Anti-tubercular Agents. Aziz Ali, A., D. Gogoi, A.K. Chaliha, A.K. Buragohain, P. Trivedi, P.J. Saikia, P.S. Gehlot, A. Kumar, V. Chaturvedi, and D. Sarma. Bioorganic & Medicinal Chemistry Letters, 2017. 27(16): p. 3698-3703. PMID[28712709].
[PubMed]. TB_07_2017.
7. One-pot Microwave Assisted Stereoselective Synthesis of Novel Dihydro-2'H-spiro[indene-2,1'-pyrrolo-[3,4-c]pyrrole]-tetraones and Evaluation of Their Antimycobacterial Activity and Inhibition of Ache. Bharkavi, C., S. Vivek Kumar, M. Ashraf Ali, H. Osman, S. Muthusubramanian, and S. Perumal. Bioorganic & Medicinal Chemistry Letters, 2017. 27(14): p. 3071-3075. PMID[28552337].
[PubMed]. TB_07_2017.
8. Discovery and Optimization of NAD(+)-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds. Bi, F.C., R.X. Ma, and S.T. Ma. Current Pharmaceutical Design, 2017. 23(14): p. 2117-2130. PMID[27784238].
[PubMed]. TB_07_2017.
9. Synthesis of New Fluoro-benzimidazole Derivatives as an Approach towards the Discovery of Novel Intestinal Antiseptic Drug Candidates. Cevik, U.A., B.N. Saglik, Y. Ozkay, Z. Canturk, J. Bueno, F. Demirci, and A.S. Koparal. Current Pharmaceutical Design, 2017. 23(15): p. 2276-2286. PMID[27908268].
[PubMed]. TB_07_2017.
10. New Isoflavonoids from the Extract of Rhynchosia precatoria (Humb. & Bonpl. ex Willd.) DC. And Their Antimycobacterial Activity. Coronado-Aceves, E.W., G. Gigliarelli, A. Garibay-Escobar, R.E.R. Zepeda, M. Curini, J. Lopez Cervantes, C.I. Ines Espitia-Pinzon, S. Superchi, S. Vergura, and M.C. Marcotullio. Journal of Ethnopharmacology, 2017. 206: p. 92-100. PMID[28506901].
[PubMed]. TB_07_2017.
11. Bis(Diphenylphosphino)amines-containing Ruthenium cymene Complexes as Potential anti-Mycobacterium tuberculosis Agents. da Silva, J.P., I.C. Silva, F.R. Pavan, D.F. Back, and M.P. de Araujo. Journal of Inorganic Biochemistry, 2017. 173: p. 134-140. PMID[28521188].
[PubMed]. TB_07_2017.
12. Hydroquinone Derivatives from the Marine-derived Fungus Gliomastix sp. Elnaggar, M.S., W. Ebrahim, A. Mandi, T. Kurtan, W.E.G. Muller, R. Kalscheuer, A. Singab, W.H. Lin, Z. Liu, and P. Proksch. RSC Advances, 2017. 7(49): p. 30640-30649. ISI[000403668900018].
[WOS]. TB_07_2017.
13. Synthesis of Carbohydrate-substituted Isoxazoles and Evaluation of Their Antitubercular Activity. Hajlaoui, K., A. Guesmi, N. Ben Hamadi, and M. Msaddek. Heterocyclic Communications, 2017. 23(3): p. 225-229. ISI[000405305900011].
[WOS]. TB_07_2017.
14. Structure-based Rational Design of Novel Inhibitors against Fructose-1,6-bisphosphate Aldolase from Candida albicans. Han, X.Y., X.Y. Zhu, Z.Q. Hong, L. Wei, Y.L. Ren, F. Wan, S.H. Zhu, H. Peng, L. Guo, L. Rao, L.L. Feng, and J. Wan. Journal of Chemical Information and Modeling, 2017. 57(6): p. 1426-1438. PMID[28475320].
[PubMed]. TB_07_2017.
15. Antitubercular and Antimicrobial Activity of NH4VO3 Promoted 1,4-Dihydropyridine Incorporated 1,3,4-Trisubstituted Pyrazole. Harikrishna, N., A.M. Isloor, K. Ananda, T. Parish, J. Jamalis, H.A. Ghabbour, and H.K. Fun. Letters in Drug Design & Discovery, 2017. 14(6): p. 699-711. ISI[000404984700008].
[WOS]. TB_07_2017.
16. Synthesis and Biological Evaluation of Indole Core-based Derivatives with Potent Antibacterial Activity against Resistant Bacterial Pathogens. Hong, W., J. Li, Z. Chang, X. Tan, H. Yang, Y. Ouyang, Y. Yang, S. Kaur, I.C. Paterson, Y.F. Ngeow, and H. Wang. The Journal of Antibiotics, 2017. 70(7): p. 832-844. PMID[28465626].
[PubMed]. TB_07_2017.
17. Identification of Promising DNA GyrB Inhibitors for Tuberculosis Using Pharmacophore-based Virtual Screening, Molecular Docking and Molecular Dynamics Studies. Islam, M.A. and T.S. Pillay. Chemical Biology & Drug Design, 2017. 90(2): p. 282-296. PMID[28109130].
[PubMed]. TB_07_2017.
18. 2-Aminoimidazoles Potentiate beta-Lactam Antimicrobial Activity against Mycobacterium tuberculosis by reducing beta-Lactamase Secretion and Increasing Cell Envelope Permeability. Jeon, A.B., A. Obregon-Henao, D.F. Ackart, B.K. Podell, J.M. Belardinelli, M. Jackson, T.V. Nguyen, M.S. Blackledge, R.J. Melander, C. Melander, B.K. Johnson, R.B. Abramovitch, and R.J. Basaraba. Plos One, 2017. 12(7): p. e0180925. PMID[28749949].
[PubMed]. TB_07_2017.
19. Structural and Inhibition Analysis of Novel Sulfur-rich 2-Mercaptobenzothiazole and 1,2,3-Triazole Ligands against Mycobacterium tuberculosis DprE1 Enzyme. Karan, S., V.K. Kashyap, S. Shafi, and A.K. Saxena. Journal of Molecular Modeling, 2017. 23(8): p. 241. PMID[28744747].
[PubMed]. TB_07_2017.
20. Evaluation of the Mycobactericidal Effect of Thio-functionalized Carbohydrate Derivatives. Korycka-Machala, M., A. Brzostek, B. Dziadek, M. Kawka, T. Poplawski, Z.J. Witczak, and J. Dziadek. Molecules, 2017. 22(5): E812. PMID[28509874].
[PubMed]. TB_07_2017.
21. Structure-based Optimization of Pyridoxal 5'-Phosphate-dependent Transaminase Enzyme (BioA) Inhibitors That Target Biotin Biosynthesis in Mycobacterium tuberculosis. Liu, F., S. Dawadi, K.M. Maize, R. Dai, S.W. Park, D. Schnappinger, B.C. Finzel, and C.C. Aldrich. Journal of Medicinal Chemistry, 2017. 60(13): p. 5507-5520. PMID[28594172].
[PubMed]. TB_07_2017.
22. Benzylsulfanyl benzo-heterocycle amides and hydrazones as New Agents against Drug-susceptible and Resistant Mycobacterium tuberculosis. Lu, X.Y., X.L. Hu, Z.Y. Liu, T.Y. Zhang, R.B. Wang, B.J. Wan, S.G. Franzblau, and Q.D. You. MedChemComm, 2017. 8(6): p. 1303-1306. ISI[000404076200018].
[WOS]. TB_07_2017.
23. In Vitro and in Silico Analysis of beta-Lactam Derivatives as Antimycobacterial Agents. Luna-Herrera, J., E.E. Lara-Ramirez, A.R. Munoz-Duarte, F.E. Olazaran, M.J. Chan-Bacab, R. Moo-Puc, A.M. Perez-Vazquez, C.M. Morales-Reyes, and G. Rivera. Letters in Drug Design & Discovery, 2017. 14(7): p. 782-786. ISI[000404985900004].
[WOS]. TB_07_2017.
24. Preparation and Evaluation of Potent Pentafluorosulfanyl-substituted Anti-tuberculosis Compounds. Moraski, G.C., R. Bristol, N. Seeger, H.I. Boshoff, P.S. Tsang, and M.J. Miller. ChemMedChem, 2017. 12(14): p. 1108-1115. PMID[28654200].
[PubMed]. TB_07_2017.
25. Synthesis of Novel Fluorene bisamide Derivatives via Ugi Reaction and Evaluation Their Biological Activity against Mycobacterium Species. Rezayan, A.H., S. Hariri, P. Azerang, G. Ghavami, I. Portugal, and S. Sardari. Iranian Journal of Pharmaceutical Research, 2017. 16(2): p. 734-744. ISI[000404966900035].
[WOS]. TB_07_2017.
26. Southeast Asian Medicinal Plants as a Potential Source of Antituberculosis Agent. Sanusi, S.B., M.F. Abu Bakar, M. Mohamed, S.F. Sabran, and M.M. Mainasara. Evidence-Based Complementary and Alternative Medicine, 2017. 7185649: 39pp. ISI[000404913700001].
[WOS]. TB_07_2017.
27. An Evaluation of Minor Groove Binders as Anti-fungal and Anti-mycobacterial Therapeutics. Scott, F.J., R.J.O. Nichol, A.I. Khalaf, F. Giordani, K. Gillingwater, S. Ramu, A. Elliott, J. Zuegg, P. Duffy, M.J. Rosslee, L. Hlaka, S. Kumar, M. Ozturk, F. Brombacher, M. Barrett, R. Guler, and C.J. Suckling. European Journal of Medicinal Chemistry, 2017. 136: p. 561-572. PMID[28544982].
[PubMed]. TB_07_2017.
28. Anti-Mycobacterium Avium Complex Activity of Clarithromycin, Rifampin, Rifabutin, and Ethambutol in Combination with Adenosine 5'-Triphosphate. Tatano, Y., S. Yamabe, C. Sano, and H. Tomioka. Diagnostic Microbiology and Infectious Disease, 2017. 88(3): p. 241-246. PMID[28511780].
[PubMed]. TB_07_2017.
29. A Novel Protein Kinase Inhibitor IMB-YH-8 with Anti-tuberculosis Activity. Xu, J., J.X. Wang, J.M. Zhou, C.L. Xu, B. Huang, Y. Xing, B. Wang, R. Luo, Y.C. Wang, X.F. You, Y. Lu, and L.Y. Yu. Scientific Reports, 2017. 7(5093): 10pp. PMID[28698545]. PMCID[PMC5506005].
[PubMed]. TB_07_2017.
30. Synthesis and in Vitro Antimycobacterial and Antibacterial Activity of 8-OMe ciprofloxacin-hydrozone/azole Hybrids. Xu, Z., S. Zhang, L.S. Feng, X.N. Li, G.C. Huang, Y. Chai, Z.S. Lv, H.Y. Guo, and M.L. Liu. Molecules, 2017. 22(7): E1171. PMID[28703766].
[PubMed]. TB_07_2017.
31. Design, Synthesis and in Vitro Anti-mycobacterial Evaluation of Gatifloxacin-1H-1,2,3-triazole-isatin Hybrids. Xu, Z., S. Zhang, X. Song, M. Qiang, and Z. Lv. Bioorganic & Medicinal Chemistry Letters, 2017. 27(16): p. 3643-3646. PMID[28720502].
[PubMed]. TB_07_2017.
32. Clathrin-independent Killing of Intracellular Mycobacteria and Biofilm Disruptions Using Synthetic Antimicrobial Polymers. Yavvari, P.S., S. Gupta, D. Arora, V.K. Nandicoori, A. Srivastava, and A. Bajaj. Biomacromolecules, 2017. 18(7): p. 2024-2033. PMID[28561567].
[PubMed]. TB_07_2017.
Patent Citations
33. Inhibition of Intracellular Growth of Mycobacterium Species and Its Applications Using a Compound That Enhances the Activity of an NAD+-Dependent Deacetylase Such as Sirtuins. Singhal, A. and C. Cheng. Patent. 2017. 2017-SG50021 2017123161: 200pp.
[Patent]. TB_07_2017.